# Whole Blood Point of Care Metabolic Measurement - SB1

> **NIH NIH SB1** · SEQUITUR HEALTH CORP. · 2024 · $1,000,000

## Abstract

PROJECT SUMMARY
 Persons of all ages with certain metabolic disorders are at-risk for metabolic crises when a certain
metabolite accumulates in the blood. While this metabolite can be measured in a clinical laboratory, currently
there is no home-based device to monitor the metabolite that causes the metabolic crises.
 Patients, their caregivers, and the doctors who specialize in these metabolic disorders strongly believe
that a home measurement device would enable significantly improved metabolite control and health
outcomes. Through work in Phase II awards from the National Institutes of Health (R44HD107897) and the
National Science Foundation (2111884), the company has developed demonstrably excellent technology that
enables accurate measurement of the metabolite in a single drop of blood.
 This proposal is submitted as a Commercialization Readiness Pilot to perform late stage development
and commercialization activities needed to overcome key software development, hardware manufacturing,
and regulatory challenges necessary to bring the at home product to market.

## Key facts

- **NIH application ID:** 11008473
- **Project number:** 1SB1HD116629-01
- **Recipient organization:** SEQUITUR HEALTH CORP.
- **Principal Investigator:** Marylaura Lind Thomas
- **Activity code:** SB1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,000,000
- **Award type:** 1
- **Project period:** 2024-09-17 → 2027-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11008473

## Citation

> US National Institutes of Health, RePORTER application 11008473, Whole Blood Point of Care Metabolic Measurement - SB1 (1SB1HD116629-01). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11008473. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*